| dc.contributor.author | Kister, Ilya | |
| dc.contributor.author | Bacon, Tamar | |
| dc.contributor.author | Shaygannejad, Vahid | |
| dc.contributor.author | Hor, Jyh Yung | |
| dc.contributor.author | Alroughani, Raed | |
| dc.contributor.author | Haas, Shannon | |
| dc.contributor.author | Devranis, Paschalis | |
| dc.date.accessioned | 2020-06-21T13:33:34Z | |
| dc.date.available | 2020-06-21T13:33:34Z | |
| dc.date.issued | 2016 | |
| dc.identifier.issn | 0028-3878 | |
| dc.identifier.issn | 1526-632X | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/13383 | |
| dc.description | 68th Annual Meeting of the American-Academy-of-Neurology (AAN) -- APR 15-21, 2016 -- Vancouver, CANADA | en_US |
| dc.description | McCombe, Pamela/0000-0003-2704-8517; Lugaresi, Alessandra/0000-0003-2902-5589; | en_US |
| dc.description | WOS: 000411328604297 | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | Amer Acad Neurol | en_US |
| dc.description.sponsorship | Bayer HealthcareBayer AGBayer Healthcare Pharmaceuticals; Bogen Idec; Genzyme/SanofiGenzyme Corporation; EMD SeronoMerck Serono; NovartisNovartis; Teva CNS; BiogenBiogen; BayerBayer AG; Biogen IdecBiogen; MerckMerck & Company; BARD; Bayer ScheringBayer AG; Sanofi AventisSanofi-Aventis; Merck SeronoMerck SeronoMerck & Company | en_US |
| dc.description.sponsorship | Dr. Kister has nothing to disclose. Dr. Bacon has nothing to disclose. Dr. Shaygannejad has nothing to disclose. Dr. Hor has nothing to disclose. Dr. Alroughani has nothing to disclose. Dr. Haas has nothing to disclose. Dr. Terzi has nothing to disclose. Dr Boz has nothing to disclose. Dr. Olascoaga has nothing to disclose. Dr McCombe has nothing to disclose. Dr. Fragoso has nothing to disclose. Dr. Lugaresi has received personal compensation for activtiies with Bayer Healthcare, Bogen Idec, Genzyme/Sanofi, EMD Serono, Novartis, and Teva CNS. Dr. Lugaresi has received research support from Bayer Healthcare and Biogen. Dr. Sola has nothing to disclose. Dr. Vucic has nothing to disclose. Dr. Pucci has nothing to disclose. Dr. Al-Harbi has nothing to disclose. Dr. Sajedi has nothing to disclose. Dr. Rojas has nothing to disclose. Dr. Patrucco has nothing to disclose. Dr Cristiano has received personal compensation for activities with Bayer, Biogen Idec, Merck, and Novartis. Dr Suarez has received personal compensation for activities with BARD as a speaker. Dr. Tsolaki has nothing to disclose. Dr. Taylor has nothing to disclose. Dr. Iuliano has received personal compensation for activities with Bayer Schering, Sanofi Aventis, Merck Serono, Novartis and Biogen Idec as travel/accommodations and meeting expenses. Dr. Devranis has nothing to disclose. Dr. Marriott has nothing to disclose. Dr. Butzkueven has received personal compensation for activities with Novartis, Merck Serono, and Biogen Idec as a consultant and/or advisor. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Lippincott Williams & Wilkins | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Prospectively tracking disease course and treatment changes in Neuromyelitis Optica using NMOBase, a global online registry. | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 86 | en_US |
| dc.relation.journal | Neurology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
